Shukra Pharmaceuticals (NSE:SHUKRAPHAR) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SHUKRAPHAR Shukra Pharmaceuticals Ltd NSE:SHUKRAPHAR
61 GF Score
Price ₹41.55
GF Value ₹8.56
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Shukra Pharmaceuticals Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

NSE:SHUKRAPHAR
61GF Score
Shukra Pharmaceuticals Ltd NSE:SHUKRAPHAR
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shukra Pharmaceuticals (NSE:SHUKRAPHAR) Overvalued in 2026?

Based on GuruFocus' analysis, Shukra Pharmaceuticals stock appears to be overvalued. The current stock price of ₹41.55 is trading 385.4% above its estimated GF Value™ of ₹8.56. GuruFocus considers Shukra Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:SHUKRAPHAR:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ₹8.56 vs. price of ₹41.55 (385.4% above fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the NSE:SHUKRAPHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shukra Pharmaceuticals Business Description

Comparable Companies
Other Exchanges 524632:India
Address Judges Bunglow Road, Bodakdev, 3rd Floor, Dev House, Opposite WIAA Office, Ahmedabad, GJ, IND, 380054
Shukra Pharmaceuticals Ltd is engaged in the business of manufacturing and trading pharmaceutical products. The company markets its products in India and international markets. The company has two operating segments: Pharmaceutical and Laboratory. Its product portfolio includes antibiotics, quinolones, macrolides, antibacterials, antifungals, antimalarials, antivirals, antiprotozoals, anthelmintics, antidepressants, antimanics, antiemetics, beta-blockers, analgesics, muscle relaxants, antituberculosis agents, vitamin products, antiallergics, corticosteroids, hyperglycemic and hypoglycemic agents, and others. It exports its products to Australia, Uganda, Kenya, the United Kingdom, Sri Lanka, Mauritius, and the Republic of Yemen.
61GF Score

Get the complete analysis for NSE:SHUKRAPHAR

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹41.55
Price
₹8.56
GF Value